Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mavu Bio Technologies is a South African biotechnology company focused on biological solutions for environmental remediation rather than human therapeutics. The company appears to supply microbial and enzyme-based products used in wastewater, sewage, and fats-oils-grease remediation, with Eco-flush and Ergofito-branded products cited in academic and trade sources. Published wastewater studies describe Eco-flush as a biological or enzyme-producing microbial treatment supplied by Mavu for pretreatment of high-fat industrial effluents such as poultry and abattoir wastewater. The company therefore fits better as an environmental/industrial biotech supplier than as a life sciences drug developer, and no evidence was found of a clinical-stage pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mavu Bio Technologies.